Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-06

Clinical Trial Update: Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B Hemoperfusion

View source ↗

Summary

Clinical trial update on the safety and efficacy of a heparin dosing score protocol during Polymyxin-B hemoperfusion for septic shock. The status of the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)
  • POLYMYXIN B (POLYMYXIN B SULFATE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Septic Shock, Polymyxin B Hemoperfusion | Status: UNKNOWN